Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    (NCCAM) [SPONSOR-COLLABORATORS] (hepatic steatosis) [CONDITION]
Show Display Options
Rank Status Study
1 Terminated The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics
Conditions: Fatty Liver;   Hepatic Steatosis;   Diabetes Mellitus;   Liver Diseases
Intervention: Drug: Probiotic-containing powder
2 Completed Phase I Trial of Silymarin for Chronic Liver Diseases
Conditions: Hepatitis C;   Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Placebo;   Drug: Silymarin
3 Completed Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Steatohepatitis;   Fatty Liver
Interventions: Drug: Omega 3 Fish Oil supplements;   Drug: Placebo

Indicates status has not been verified in more than two years